上礼拜一，港资瑞安房地产一纸公告，让上海豪宅圈心头一紧。 公司把新天地板块的"顶流"——翠湖天地五期一套213平的房子，以3050万的总价，卖给了CEO的家属，算下来单价14.26万/平。到目前为止，网上房地产 数据显示，这个房源还没网签。 这笔交易最刺眼的地方，在于它重新锚定了"塔尖"豪宅的价格。 这价格一夜之间回到了翠湖天地五期2021年的开盘价。比同小区的二手房低。甚至，比法拍房，都还要低。 这就像茅台官方突然按出厂价向内部放货，让市场上那些囤货待涨的"信仰"，晃了三晃。 | 编号 | 预售许可证/房地产权证 | 开盘日期 | 总言数 | | --- | --- | --- | --- | | 023467 | 沪(2022)黄字不动产权第005213号 | 2022-10-27 | 262 | | 022697 | 黄浦房管(2021)预字0000233号 | 2021-10-14 | 106 | | 021773 | 黄浦房管(2020)预字0000104号 | 2020-06-24 | 132 | 在新天地板块，乃至整个上海豪宅市场，翠湖天地系列有着风向标意义。 N年前开始，瑞安通过旧改拿地，建成 ...

Core Viewpoint - The company is a leading domestic producer of toluenesulfonic acid, with a diverse production capability ranging from low to high concentration products, serving various industries including pharmaceuticals, construction materials, high-end casting, electronics, dyeing, and batteries [2] Group 1: Company Operations - The company is actively expanding its market for toluenesulfonic acid by closely monitoring downstream industry demand [2] - The company has established its own production line for glyoxylic acid, a key raw material for the production of L-phenylglycine, and participated in the formulation of the industry standard for glyoxylic acid (HG/T6143-2023) in 2023 [2] - Currently, glyoxylic acid is primarily used in the production of the company's leading product, L-phenylglycine [2] Group 2: Market Environment - The company's stock price fluctuations are influenced by various factors including macroeconomic conditions, industry cycles, and market sentiment [2] - The company aims to adhere to its strategic goals by focusing on innovation and scientific development, while enhancing operational management to improve business efficiency and reward investor trust and support [2]

Group 1 - The company has successfully transformed traditional cooking techniques into a thriving business, with the cooking skill of lamb feet now recognized as an intangible cultural heritage of Xiushan County [2] - In 2016, the company was established, combining traditional craftsmanship with modern food processing, leading to the development of over 20 new products [2] - The company expanded its restaurant space to 1,000 square meters by 2019, achieving peak daily revenues exceeding 60,000 yuan [2] Group 2 - The company established a black goat breeding base covering over 200 acres in 2020, promoting a "company + base + farmers" model to support local farmers [2] - More than 100 households in the county are now engaged in goat farming, with each household potentially increasing their income by over 30,000 yuan annually [2] - The company has ventured into e-commerce since 2018, generating nearly 10 million yuan in online revenue this year, while also helping local farmers sell their products [3] Group 3 - The company aims to build a standardized supply chain to enhance its brand and strengthen local industries, ensuring that more villagers can improve their livelihoods [3] - The journey of the company reflects the hard work and determination of the local people, emphasizing that prosperity is achieved through effort rather than waiting for opportunities [3]

Core Viewpoint - The company has successfully transformed traditional culinary skills into a thriving business, contributing to local economic development and community prosperity through innovative practices and collaboration with local farmers [1][2][3]. Group 1: Business Development - The company started with a small 70-square-meter shop specializing in lamb feet, which initially struggled but later saw daily revenue increase from 400 yuan to 2,000 yuan within a year [1]. - In 2016, the company was established to combine traditional skills with modern food processing, leading to the development of over 20 new products, including spicy lamb tripe and mustard lamb [2]. - By 2019, the company expanded its lamb restaurant to 1,000 square meters, achieving peak daily revenues exceeding 60,000 yuan [2]. Group 2: Community Engagement - The company established a black goat breeding base covering over 200 acres in 2020, implementing a "company + base + farmers" model to support local farmers with breeding stock and technical guidance [2]. - More than 100 local households are now involved in goat farming, with each household potentially increasing their income by over 30,000 yuan annually [2]. Group 3: E-commerce and Market Expansion - The company began exploring e-commerce in 2018 and formed a professional team in 2023, achieving nearly 10 million yuan in online revenue this year [3]. - The company not only sells its own lamb products but also helps local farmers sell other mountain goods, thereby increasing their income [3]. Group 4: Future Aspirations - The company aims to build a standardized supply chain to enhance its brand and strengthen local industries, ensuring that more community members can benefit from economic growth [3].

Group 1 - The company, Xintiandi, reported that as of December 10, 2025, the number of shareholders is 18,309 [2]

Group 1 - The first residential land parcel "05-02" in Zhaojialou Ancient Town, located in Minhang District, is officially listed for sale, marking a significant step in the area's urban renewal [3] - The land is planned for 211 residential units with a plot ratio of approximately 1.2, indicating a low-density development [3] - The project aims to create a micro-vacation destination that integrates cultural tourism and residential living, with at least 50% of the residential units to be fully decorated to a standard of no less than 3000 yuan per square meter [3]

公开资料显示，新天地从事研发、生产和销售医药中间体、原料药及制剂产品，产品覆盖抗感染、糖尿 病、心血管疾病、局部麻醉等多个治疗领域。 富马酸亚铁是一种用于预防和治疗缺铁性贫血的铁剂，通过补充铁元素改善血红蛋白合成，缓解贫血相 关症状。 新天地表示，公司取得的富马酸亚铁原料药《化学原料药上市申请批准通知书》，表明该原料药已符合 国家药品注册的有关规定要求，将进一步丰富公司的产品结构，提升市场竞争力。 本报讯(记者肖艳青)12月9日晚间，新天地（301277）药业股份有限公司(以下简称"新天地")公告称，公 司于12月8日收到国家药品监督管理局核准签发的富马酸亚铁原料药《化学原料药上市申请批准通知 书》。 ...

中证报中证网讯(王珞)12月9日晚，新天地（301277）发布公告，公司于2025年12月8日收到国家药品监 督管理局核准签发的富马酸亚铁原料药《化学原料药上市申请批准通知书》，通知书有效期至2030年12 月7日。 新天地表示，本次公司取得的富马酸亚铁原料药《化学原料药上市申请批准通知书》，表明该原料药已 符合国家药品注册的有关规定要求，将进一步丰富公司的产品结构，提升市场竞争力。 富马酸亚铁是一种用于预防和治疗缺铁性贫血的铁剂，通过补充铁元素改善血红蛋白合成，缓解贫血相 关症状。 ...

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

Core Viewpoint - Xintiandi (301277.SZ) has received approval from the National Medical Products Administration for the raw material drug Ferrous Fumarate, which is used for the prevention and treatment of iron deficiency anemia [1] Group 1 - The approval includes the issuance of the "Chemical Raw Material Drug Marketing Application Approval Notice" for Ferrous Fumarate [1] - Ferrous Fumarate is an iron supplement that improves hemoglobin synthesis and alleviates symptoms related to anemia [1]